All-trans retinoic acid plus low-dose rituximab vs low-dose rituximab in corticosteroid-resistant or relapsed ITP
| Autor: | Wu, Ye-Jun 1, 2, 3, 4, *, Liu, Hui 5, *, Zeng, Qiao-Zhu 1, 2, 3, 4, Liu, Yi 6, Wang, Jing-Wen 7, Wang, Wen-Sheng 8, Jia-Feng 9, Zhou, He-Bing 10, Huang, Qiu-Sha 1, 2, 3, 4, He, Yun 1, 2, 3, 4, Fu, Hai-Xia 1, 2, 3, 4, Zhu, Xiao-Lu 1, 2, 3, 4, Jiang, Qian 1, 2, 3, 4, Jiang, Hao 1, 2, 3, 4, Chang, Ying-Jun 1, 2, 3, 4, Xu, Lan-Ping 1, 2, 3, 4, Huang, Xiao-Jun 1, 2, 3, 4, *, Zhang, Xiao-Hui 1, 2, 3, 4, * |
|---|---|
| Zdroj: | In Blood 20 January 2022 139(3):333-342 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|